First Choice Neurology, the largest neurology group in the United States, is set to make medical history this week as Dr. Jennifer Buczyner and Dr. Jeff Gelblum are among the […]
First Choice Neurology Administers New Alzheimer’s Drug Kisunla Read More »
The FDA approved the new Alzheimer’s drug lecanemab (BAN2401), which will be sold under the brand name Leqembi developed by Eisai and Biogen last week for patients with mild cognitive
A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after data from more patients in two discontinued studies showed that the drug improved cognition at
Biogen Seeks FDA Approval for New Alzheimer’s Drug Read More »
